Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-723

6 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 63323-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remif-struc-01.jpg (Remif Struc 01)

Remif-struc-01.jpg (Remif Struc 01)
Chemical structure of remifentanil hydrochloride showing its molecular composition including acetyl groups, a piperidine ring, and a phenyl group with hydrochloride.*
FDA Label Image

Remif-img-01.jpg (Remif Img 01)

Remif-img-01.jpg (Remif Img 01)
A line graph depicting minute ventilation as a percentage of baseline over time in minutes. Two lines represent Remifentanil Hydrochloride (n=11) and Alfentanil (n=10). The graph shows values during infusion and post-infusion periods, with distinct changes noted at the 180-minute mark separating these phases.*
FDA Label Image

Remif-img-02.jpg (Remif Img 02)

Remif-img-02.jpg (Remif Img 02)
A pharmacokinetic chart depicting mean serum concentration (ng/mL) over time (minutes) for two drugs: Alfentanil at 0.5 mcg/kg/min and Remifentanil Hydrochloride at 0.05 mcg/kg/min. The graph shows concentration changes with error bars, illustrating the drugs' profiles during and after infusion.*
FDA Label Image

Fresenius Kabi Logo (Rem02 0002 04)

FDA Label Image

Remif-label-01.jpg (Remif Label 01)

Remif-label-01.jpg (Remif Label 01)
Label for Remifentanil Hydrochloride injection, powder, lyophilized, for solution, 1 mg per vial. The label states the vial contains an amount equivalent to 1 mg of remifentanil, for intravenous use only, requiring reconstitution and dilution before use. The product is labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL.*
FDA Label Image

Remif-label-02.jpg (Remif Label 02)

Remif-label-02.jpg (Remif Label 02)
Label for Remifentanil Hydrochloride for Injection 1 mg per vial, a lyophilized powder for intravenous use. Contains equivalent to 1 mg remifentanil per vial. Package includes 10 single dose vials. Label indicates storage instructions and dilution guidelines. Manufactured by Fresenius Kabi USA, LLC. Features barcode and website www.fresenius-kabi.com/us.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.